Table of Contents
Hepatitis Research and Treatment
Volume 2013, Article ID 479639, 6 pages
http://dx.doi.org/10.1155/2013/479639
Clinical Study

Predictors of Health-Related Quality of Life in Outpatients with Cirrhosis: Results from a Prospective Cohort

1Department of Medicine, Copenhagen University Hospital Koge, 4600 Koege, Denmark
2Department of Medicine, Copenhagen University Hospital Gentofte, 2900 Hellerup, Denmark
3Department of Gastroenterology and Hepatology, Odense University Hospital, 5000 Odense, Denmark
4Department of Hepatology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark
5Department of Medicine, Copenhagen University Hospital Glostrup, 2600 Glostrup, Denmark
6Gastrounit, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark

Received 10 August 2013; Revised 21 November 2013; Accepted 24 November 2013

Academic Editor: Yoichi Hiasa

Copyright © 2013 Maja Thiele et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Propst, T. Propst, G. Zangerl, D. Ofner, G. Judmaier, and W. Vogel, “Prognosis and life expectancy in chronic liver disease,” Digestive Diseases and Sciences, vol. 40, no. 8, pp. 1805–1815, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. H. T. Sørensen, A. M. Thulstrup, L. Mellemkjar et al., “Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark,” Journal of Clinical Epidemiology, vol. 56, no. 1, pp. 88–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. D'Amico, G. Garcia-Tsao, and L. Pagliaro, “Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies,” Journal of Hepatology, vol. 44, no. 1, pp. 217–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Thiele, A. Krag, U. Rohde, and L. L. Gluud, “Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 10, pp. 1155–1165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. L. Gluud, K. Christensen, E. Christensen, and A. Krag, “Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome,” Hepatology, vol. 51, no. 2, pp. 576–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Wiest, A. Krag, and A. Gerbes, “Spontaneous bacterial peritonitis: recent guidelines and beyond,” Gut, vol. 61, no. 2, pp. 297–310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. EASL-EORTC, “EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma,” Journal of Hepatology, vol. 56, pp. 908–943, 2012. View at Google Scholar
  8. J. S. Bajaj, “Review article: the modern management of hepatic encephalopathy,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 5, pp. 537–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Arguedas, T. G. DeLawrence, and B. M. McGuire, “Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis,” Digestive Diseases and Sciences, vol. 48, no. 8, pp. 1622–1626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Fritz and J. Hammer, “Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 4, pp. 460–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Holecek, “Three targets of branched-chain amino acid supplementation in the treatment of liver disease,” Nutrition, vol. 26, no. 5, pp. 482–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Marchesini, G. Bianchi, P. Amodio et al., “Factors associated with poor health-related quality of life of patients with cirrhosis,” Gastroenterology, vol. 120, no. 1, pp. 170–178, 2001. View at Google Scholar · View at Scopus
  13. I. Les, E. Doval, M. Flavia et al., “Quality of life in cirrhosis is related to potentially treatable factors,” European Journal of Gastroenterology & Hepatology, vol. 22, pp. 221–227, 2010. View at Google Scholar
  14. Z. M. Younossi, N. Boparai, L. L. Price, M. L. Kiwi, M. McCormick, and G. Guyatt, “Health-related quality of life in chronic liver disease: the impact of type and severity of disease,” American Journal of Gastroenterology, vol. 96, no. 7, pp. 2199–2205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Kalaitzakis, M. Simrén, R. Olsson et al., “Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life,” Scandinavian Journal of Gastroenterology, vol. 41, no. 12, pp. 1464–1472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Z.-J. Bao, D.-K. Qiu, X. Ma et al., “Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy,” World Journal of Gastroenterology, vol. 13, no. 21, pp. 3003–3008, 2007. View at Google Scholar · View at Scopus
  17. J. S. Bajaj, J. Cordoba, K. D. Mullen et al., “Review article: the design of clinical trials in hepatic encephalopathy—an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 7, pp. 739–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. M. Younossi, G. Guyatt, M. Kiwi, N. Boparai, and D. King, “Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease,” Gut, vol. 45, no. 2, pp. 295–300, 1999. View at Google Scholar · View at Scopus
  19. S.-E. Christensen, P. Elsass, and H. Vilstrup, “Number connection test and continuous reaction times in non-encephalopathic patients: a comparative study,” Journal of Applied Toxicology, vol. 1, no. 5, pp. 262–263, 1981. View at Google Scholar · View at Scopus
  20. P. Elsass, “Continuous reaction times in cerebral dysfunction,” Acta Neurologica Scandinavica, vol. 73, no. 3, pp. 225–246, 1986. View at Google Scholar · View at Scopus
  21. P. Elsass, S. E. Christensen, E. L. Mortensen, and H. Vilstrup, “Discrimination between organic and hepatic encephalopathy by means of continuous reaction times,” Liver, vol. 5, no. 1, pp. 29–34, 1985. View at Google Scholar · View at Scopus
  22. P. Elsass, S. E. Christensen, and L. Ranek, “Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness,” Scandinavian Journal of Gastroenterology, vol. 16, no. 3, pp. 441–447, 1981. View at Google Scholar · View at Scopus
  23. M. M. Lauridsen, H. Gronbaek, E. B. Naeser et al., “Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis,” Metabolic Brain Disease, vol. 27, no. 4, pp. 559–565, 2012. View at Publisher · View at Google Scholar
  24. M. M. Lauridsen, P. Jepsen, and H. Vilstrup, “Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease,” Metabolic Brain Disease, vol. 26, no. 2, pp. 135–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Hoekstra, J. H. M. Goosen, G. S. de Wolf, and C. C. P. M. Verheyen, “Effectiveness of multidisciplinary nutritional care on nutritional intake, nutritional status and quality of life in patients with hip fractures: a controlled prospective cohort study,” Clinical Nutrition, vol. 30, no. 4, pp. 455–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Nourissat, M. P. Vasson, Y. Merrouche et al., “Relationship between nutritional status and quality of life in patients with cancer,” European Journal of Cancer, vol. 44, no. 9, pp. 1238–1242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Amodio, C. Bemeur, R. Butterworth et al., “The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus,” Hepatology, vol. 58, pp. 325–336, 2013. View at Google Scholar
  28. Y. Nakaya, K. Okita, K. Suzuki et al., “BCAA-enriched snack improves nutritional state of cirrhosis,” Nutrition, vol. 23, no. 2, pp. 113–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Marchesini, G. Bianchi, M. Merli et al., “Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial,” Gastroenterology, vol. 124, no. 7, pp. 1792–1801, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. L. D. Plank, E. J. Gane, S. Peng et al., “Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial,” Hepatology, vol. 48, no. 2, pp. 557–566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Chen, X. Wang, J. Wang, Z. Yan, and J. Luo, “Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies,” European Journal of Cancer, vol. 48, no. 14, pp. 2137–2145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Naveau, V. Giraud, E. Borotto, A. Aubert, F. Capron, and J.-C. Chaput, “Excess weight risk factor for alcoholic liver disease,” Hepatology, vol. 25, no. 1, pp. 108–111, 1997. View at Google Scholar · View at Scopus
  33. R. K. Dhiman, R. Kurmi, K. K. Thumburu et al., “Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver,” Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2381–2390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Prasad, R. K. Dhiman, A. Duseja, Y. K. Chawla, A. Sharma, and R. Agarwal, “Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy,” Hepatology, vol. 45, no. 3, pp. 549–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Bajaj, J. B. Wade, D. P. Gibson et al., “The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers,” American Journal of Gastroenterology, vol. 106, no. 9, pp. 1646–1653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Moscucci, S. Nardelli, I. Pentassuglio et al., “Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients,” Liver International, vol. 31, no. 10, pp. 1505–1510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Wunsch, B. Szymanik, M. Post, W. Marlicz, M. Mydłowska, and P. Milkiewicz, “Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study,” Liver International, vol. 31, no. 7, pp. 980–984, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-H. Tan, G. H. Lee, K. T. J. Thia, H. S. Ng, W. C. Chow, and H. F. Lui, “Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study,” Singapore Medical Journal, vol. 50, no. 3, pp. 255–260, 2009. View at Google Scholar · View at Scopus
  39. H. Schomerus and W. Hamster, “Quality of life in cirrhotics with minimal hepatic encephalopathy,” Metabolic Brain Disease, vol. 16, no. 1-2, pp. 37–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Arvaniti, G. D'Amico, G. Fede et al., “Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis,” Gastroenterology, vol. 139, no. 4, pp. 1246.e5–1256.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Bajaj, J. G. O'Leary, F. Wong et al., “Bacterial infections in end-stage liver disease: current challenges and future directions,” Gut, vol. 61, pp. 1219–1225, 2012. View at Google Scholar
  42. A. Tripodi and P. M. Mannucci, “The coagulopathy of chronic liver disease,” The New England Journal of Medicine, vol. 365, no. 2, pp. 147–156, 2011. View at Publisher · View at Google Scholar · View at Scopus